Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits

Life Sciences

Volumn 74, Issue 5, 2003, Pages 553-562

  Gumieniczek, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Alloxan induced diabetes; Antioxidative system; Kidney; Lipid peroxidation; Liver; Pioglitazone

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CATALASE; PIOGLITAZONE; SUPEROXIDE DISMUTASE; THIAZOLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; IN VIVO STUDY; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; RABBIT;

ANIMALIA; FELIS CATUS; ORYCTOLAGUS CUNICULUS;

EID: 0242491886     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.03.004     Document Type: Article

References (27)

1. Aebi H. Catalase in vitro. Methods in Enzymology. 105:1984;121-126.
2. Akkuş I., Kalak S., Vural H., Çaglayan O., Menekşe E., Can G., Durmuş B. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clinica Chimica Acta. 244:1996;221-227.
3. Bánhegyi G., Braun L., Çsala M., Puskás F., Mandl J. Ascorbate metabolism and its regulation in animals. Free Radical Biology and Medicine. 23(5):1997;793-803.
4. Bonnefont-Rousselot D., Bastard J.P., Jaudon M.C., Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes and Metabolism (Paris). 26:2000;163-176.
5. Ceriello A., dello Russo P., Amstad P., Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes. 45(4):1996;471-477.
6. Dandona P., Aljada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. The American Journal of Cardiology. 90(5A, Suppl. S):2002;27G-33G.
7. El-Missiry M.A., El-Gindy A.M. Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds. Annals of Nutrition and Metabolism. 44:2000;97-100.
8. Fukui T., Noma T., Mizushige K., Aki Y., Kimura S., Abe Y. Dietary troglitazone decreases oxidative stress in early stage type II diabetic rats. Life Sciences. 66(21):2000;2043-2049.
9. Füchtenbusch M., Standl E., Schatz H. Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes. 108:2000;151-163.
10. Inal M.E., Kanbak G., Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clinica Chimica Acta. 305:2001;75-80.
11. Inoue I., Goto S.I., Matsunaga T., Nakajima T., Awata T., Hokari S., Komoda T., Katayama S. The ligands/activators for peroxisome proliferator-activated receptor alfa (PPPRalfa) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism. 50(1):2001;3-11.
12. Inukai T., Takanashi K., Tayama K., Aso Y., Takemura Y. High glucose concentrations abolish the superoxide dismutase response of leukocytes to ascorbic acid or troglitazone in type 2 diabetes mellitus. Life Sciences. 70:2002;2391-2401.
13. Kakkar R., Mantha S.V., Radhi J., Prasad K., Kalra J. Antioxidant defense system in diabetic kidney: a time course study. Life Sciences. 60(9):1997;667-679.
14. Kakkar R., Mantha S.V., Radhi J., Prasad K., Kalra J. Increased oxidative stress in rat liver and pancreas durig progression of streptozotocin-induced diabetes. Clinical Science. 94(6):1998;623-632.
15. Kashiba M., Oka J., Ichikawa R., Kageyama A., Inayama T., Kageyama H., Ishikawa T., Nishikimi M., Inoue M., Inoue S. Impaired reductive regeneration of ascorbic acid in the Goto-Kakizaki diabetic rat. Biochemical Journal. 351:2000;313-318.
16. Kyaw A. A simple colorimetric method for ascorbic acid determination in blood plasma. Clinica Chimica Acta. 86:1978;153-157.
17. Lindsay R.M., Jamieson N.S., Walker S.A., McGuigan C.C., Smith W., Baird J.D. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes. Diabetologia. 41(5):1998;516-523.
18. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. The Journal of Biological Chemistry. 193:1951;265-275.
19. Madhavan G.R., Chakrabarti R., Kumar S.K.B., Misra P., Mamidi R.N.V.S., Balraju V., Kasiram K., Babu R.K., Suresh J., Lohray B.B., Lohray V.B., Iqbal J., Rajagopalan R. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents. European Journal of Medicinal Chemistry. 36:2001;627-637.
20. Matkovics B., Sasvári M., Kotormán M., Varga I.S., Hai D.Q., Varga C. Further prove on oxidative stress in alloxan diabetic rat tissues. Acta Physiologica Hungarica. 85(3):1997/98;183-192.
21. Matsuhashi N., Watanabe K., Kanamori H., Ohnishi S., Omata M. PPARγ agonists for intestinal ischaemia. The Lancet. 358:2001;75-76.
22. Qanungo S., Sen A., Mukherjea M. Antioxidant status and lipid peroxidation in human feto-placental unit. Clinica Chimica Acta. 285:1999;1-12.
23. Rahbar S., Natarajan R., Yerneni K.K., Scott S., Gonzales N., Nadler J.L. Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation. Clinica Chimica Acta. 301:2000;65-77.
24. Reddi A.S., Bollineni J.S. Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats. Biochemical and Biophysical Research Communications. 235(3):1997;598-601.
25. Sun F., Iwaguchi K., Shudo R., Nagaki Y., Tanaka K., Ikeda K., Tokumaru S., Kojo S. Change in tissue concentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes. Clinical Science. 96(2):1999;185-190.
26. Tagami S., Kondo T., Yoshida J.H., Ohtsuka Y., Kawakami Y. Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits. Metabolism. 41(10):1992;1053-1058.
27. Tüzün S., Girgin F.K., Sözmen E.Y., Mentes G., Ersöz B. Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues. Experimental and Toxicologic Pathology. 51:1999;436-441.